Currently Enrolling Trials in Kidney Transplantation
Clinical Trials - Transplantation - Kidney
Active
Principal Investigator:
Stuart Knechtle, MD, Duke University Hospital
The goal of the ADAPT study is to study whether using two drugs, carfilzomib and belatacept, together can lower the number of plasma cells in “highly sensitized” people on the kidney transplant waiting list.
Learn more: Study Summary
Clinicaltrials.gov
Study Website
Principal Investigator:
Flavio G. Vincenti, MD, University of California, San Francisco Medical Center
The goal of ATTAIN is to study whether using two drugs, daratumumab and belatacept, together can lower the number of plasma cells in “highly sensitized” people on the kidney transplant waiting list.
Learn more: Study Summary
Clinicaltrials.gov
Study Website
Principal Investigator:
Allan Kirk, MD, PhD, Duke University School of Medicine
TEACH is a clinical trial investigating whether cells from the kidney donor's bone marrow, called mesenchymal stromal cells (MSCs) will allow kidney transplant recipients to stop immunosuppressive medications.
Learn more: Study Summary
Clinicaltrials.gov
Study Website